Posted in | News

Millport to Construct Modern Facility for Manufacturing Reinforced Composite Structural Panels

Millport Associates has leased a space of 25,000 sq. ft. in the Miramar Park of Commerce, South Florida, to build a modern facility in the U.S. for producing Inovatec reinforced composite structural panels (RCSP) for the construction industry.

Guilherme de Oms Cooper, U.S. Administrative Director of the company, stated that Millport has acquired all the intellectual property, patents, assets and trademarks of the bankrupt InnoVida and has done considerable progress in exploiting the raw materials and the production method for moving this promising technology to the subsequent level.

The company is building the first high output modern manufacturing unit in Brazil out of four and is looking to offer turnkey factory operations.

Inovatec is a building technology based on highly performing materials that are connected with the aerospace, marine and other modern industries. This technology has extensively reduced the time for construction and is energy efficient. This does not need heavy equipment or specific work on the location. The design of the finished product can be resistant to earthquake and hurricane, and needs minimum maintenance all through its life. This technology is not dependent on the usual construction materials’ availability connected with the conventional systems.

Cooper stated that the company’s objective is to bring this exclusive solution to the construction industry of the U.S., Brazil and other parts of the world. Currently, the company is appraising the projects with global investors and partners, who are in search of bringing Inovatec’s owned solutions to the markets for meeting the housing deficit influencing the global areas.

Source: http://www.inovatecbrasil.com.br/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Millport to Construct Modern Facility for Manufacturing Reinforced Composite Structural Panels. AZoBuild. Retrieved on July 14, 2024 from https://www.azobuild.com/news.aspx?newsID=14660.

  • MLA

    Scanlon, Joel. "Millport to Construct Modern Facility for Manufacturing Reinforced Composite Structural Panels". AZoBuild. 14 July 2024. <https://www.azobuild.com/news.aspx?newsID=14660>.

  • Chicago

    Scanlon, Joel. "Millport to Construct Modern Facility for Manufacturing Reinforced Composite Structural Panels". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14660. (accessed July 14, 2024).

  • Harvard

    Scanlon, Joel. 2019. Millport to Construct Modern Facility for Manufacturing Reinforced Composite Structural Panels. AZoBuild, viewed 14 July 2024, https://www.azobuild.com/news.aspx?newsID=14660.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.